Arkolith/Insider Trading/CMPX/Form 4

Gordon Carl L

Director, 10% OwnerCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed Apr 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.7M
Net Open-Market Flow
-$5.7M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2025Sell(S)3.6M$1.59$5.7M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000385) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML